Biofrontera Inc.
BFRI· Nasdaq
BFRIBiofrontera Inc.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001493152-22-031682
| Metric | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|
| Revenue | $4.32M | $4.33M | $3.25M |
| Net Income | -$2.57M | -$16.01M | -$2.99M |
| EPS Diluted | -$2.26 | -$2.00 | -$2,984.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biofrontera Inc. · CIK 1858685 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
